These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

727 related articles for article (PubMed ID: 22149932)

  • 1. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs.
    Cyster JG; Schwab SR
    Annu Rev Immunol; 2012; 30():69-94. PubMed ID: 22149932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1.
    Matloubian M; Lo CG; Cinamon G; Lesneski MJ; Xu Y; Brinkmann V; Allende ML; Proia RL; Cyster JG
    Nature; 2004 Jan; 427(6972):355-60. PubMed ID: 14737169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs.
    Cyster JG
    Annu Rev Immunol; 2005; 23():127-59. PubMed ID: 15771568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
    Maeda Y; Seki N; Sato N; Sugahara K; Chiba K
    Int Immunol; 2010 Jun; 22(6):515-25. PubMed ID: 20497959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Finding a way out: lymphocyte egress from lymphoid organs.
    Schwab SR; Cyster JG
    Nat Immunol; 2007 Dec; 8(12):1295-301. PubMed ID: 18026082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
    Chiba K
    Pharmacol Ther; 2005 Dec; 108(3):308-19. PubMed ID: 15951022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.
    Chiba K; Matsuyuki H; Maeda Y; Sugahara K
    Cell Mol Immunol; 2006 Feb; 3(1):11-9. PubMed ID: 16549044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis.
    Mehling M; Johnson TA; Antel J; Kappos L; Bar-Or A
    Neurology; 2011 Feb; 76(8 Suppl 3):S20-7. PubMed ID: 21339487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function.
    Brinkmann V; Cyster JG; Hla T
    Am J Transplant; 2004 Jul; 4(7):1019-25. PubMed ID: 15196057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720.
    Kihara A; Igarashi Y
    Biochim Biophys Acta; 2008 Sep; 1781(9):496-502. PubMed ID: 18555808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Egress: a receptor-regulated step in lymphocyte trafficking.
    Rosen H; Sanna G; Alfonso C
    Immunol Rev; 2003 Oct; 195():160-77. PubMed ID: 12969317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients.
    Schwab SR; Pereira JP; Matloubian M; Xu Y; Huang Y; Cyster JG
    Science; 2005 Sep; 309(5741):1735-9. PubMed ID: 16151014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation.
    Hla T; Brinkmann V
    Neurology; 2011 Feb; 76(8 Suppl 3):S3-8. PubMed ID: 21339489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720.
    Morris MA; Gibb DR; Picard F; Brinkmann V; Straume M; Ley K
    Eur J Immunol; 2005 Dec; 35(12):3570-80. PubMed ID: 16285007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine 1-phosphate in coagulation and inflammation.
    Obinata H; Hla T
    Semin Immunopathol; 2012 Jan; 34(1):73-91. PubMed ID: 21805322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine-1-phosphate: a master regulator of lymphocyte egress and immunity.
    Simmons S; Ishii M
    Arch Immunol Ther Exp (Warsz); 2014 Apr; 62(2):103-15. PubMed ID: 24276789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The S1P-analog FTY720 differentially modulates T-cell homing via HEV: T-cell-expressed S1P1 amplifies integrin activation in peripheral lymph nodes but not in Peyer patches.
    Halin C; Scimone ML; Bonasio R; Gauguet JM; Mempel TR; Quackenbush E; Proia RL; Mandala S; von Andrian UH
    Blood; 2005 Aug; 106(4):1314-22. PubMed ID: 15870184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of fingolimod (FTY720) in lymphoid tissues contributes to prolonged efficacy.
    Sensken SC; Bode C; Gräler MH
    J Pharmacol Exp Ther; 2009 Mar; 328(3):963-9. PubMed ID: 19074680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for S1P and S1P1 in immature-B cell egress from mouse bone marrow.
    Pereira JP; Xu Y; Cyster JG
    PLoS One; 2010 Feb; 5(2):e9277. PubMed ID: 20174580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of sphingosine 1-phosphate on functions of T cell - review].
    Huang WR; Wang LS; DA WM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):718-22. PubMed ID: 16129068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.